Latest News
Ionis Pharmaceuticals, Inc.
- Form 8K Ionis Pharmaceuticals Inc For: 23 October By Investing.com
- GSK, Ionis hepatitis B functional cure breaks open market for followers
- BMO upgrades Ionis Pharmaceuticals stock rating on sHTG opportunity By Investing.com
- GSK, Ionis win US approval for first-of-its-kind hepatitis B drug
- GSK, Ionis win FDA nod for hepatitis B functional cure that controls virus after treatment
- Ionis Pharmaceuticals to host Q2 2026 financial results webcast
- Ionis Pharmaceuticals EVP research Eric Swayze sells $2,307 in stock
- Form 4 Ionis Pharmaceuticals Inc: Shannon L. Devers (EVP, Chief Human Resources Ofc) For: 15 October
- Form 144 IONIS PHARMACEUTICALS INC For: 16 October By Investing.com
- Ionis receives positive EU opinion for triglyceride drug expansion By Investing.com
- Ionis Pharmaceuticals stock hits 52-week low at 42.63 USD By Investing.com
- Ionis Pharmaceuticals stock hits 52-week low at 42.96 USD
Headlines from the last 30 days, linking to the original publishers. See all market news →